Matches in SemOpenAlex for { <https://semopenalex.org/work/W4231808644> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W4231808644 endingPage "1034" @default.
- W4231808644 startingPage "1027" @default.
- W4231808644 abstract "In Brief Objective To inform the obstetrician-gynecologist of recent scientific evidence regarding the use of supplemental folic acid for prevention of neural tube defects (NTDs). Data Sources We selected English language articles via MEDLINE published from January 1990 through February 1997, using the search terms. “folic acid” and “neural tube defect.” Additional sources were identified through crossreferencing and through searching selected journals published from March through October 1997. Methods of Study Selection Articles were selected on the basis of their relevance to the relationship between folate intake and NTD incidence, mechanisms of folate responsive NTD formation, and folate provision strategy. We referenced 55 papers in total. Tabulation, Integration, and Results The majority of evidence demonstrates a decreased incidence of NTDs with increased folic acid consumption. The most convincing trials were performed in Europe among women who were planning pregnancy by using multivitamin or folic acid supplements. Some studies suggest that the protective effect of folate is explained, in many cases, not through correction of dietary deficiencies, but through correction of metabolic defects. Other evidence implies that it reduces NTDs by causing abortion of affected conceptuses. Supplemental folic acid tablets are the most proven means of improving an individual's folate status, but ensuring compliance with a strategy using vitamin tablets is problematic. Conclusion Women of reproductive age should be advised to take multivitamin supplements containing 0.4 mg folic acid daily. Women with previously affected offspring who intend to become pregnant should take daily supplementation containing 4 mg of folic acid in the periconceptional period to reduce the risk of recurrence. Objective evidence supports the use of folic acid in the periconceptional period for the purpose of reducing the risk of neural tube defects." @default.
- W4231808644 created "2022-05-12" @default.
- W4231808644 creator A5008392439 @default.
- W4231808644 creator A5043516166 @default.
- W4231808644 date "1998-06-01" @default.
- W4231808644 modified "2023-09-23" @default.
- W4231808644 title "PREVENTING NEURAL TUBE DEFECTS" @default.
- W4231808644 doi "https://doi.org/10.1097/00006250-199806000-00031" @default.
- W4231808644 hasPublicationYear "1998" @default.
- W4231808644 type Work @default.
- W4231808644 citedByCount "2" @default.
- W4231808644 countsByYear W42318086442016 @default.
- W4231808644 countsByYear W42318086442023 @default.
- W4231808644 crossrefType "journal-article" @default.
- W4231808644 hasAuthorship W4231808644A5008392439 @default.
- W4231808644 hasAuthorship W4231808644A5043516166 @default.
- W4231808644 hasConcept C120665830 @default.
- W4231808644 hasConcept C121332964 @default.
- W4231808644 hasConcept C126322002 @default.
- W4231808644 hasConcept C131872663 @default.
- W4231808644 hasConcept C196843134 @default.
- W4231808644 hasConcept C2776551950 @default.
- W4231808644 hasConcept C2776940978 @default.
- W4231808644 hasConcept C2777003008 @default.
- W4231808644 hasConcept C2779234561 @default.
- W4231808644 hasConcept C2780594696 @default.
- W4231808644 hasConcept C2909565028 @default.
- W4231808644 hasConcept C2992130864 @default.
- W4231808644 hasConcept C54355233 @default.
- W4231808644 hasConcept C61511704 @default.
- W4231808644 hasConcept C71924100 @default.
- W4231808644 hasConcept C86803240 @default.
- W4231808644 hasConcept C95444343 @default.
- W4231808644 hasConceptScore W4231808644C120665830 @default.
- W4231808644 hasConceptScore W4231808644C121332964 @default.
- W4231808644 hasConceptScore W4231808644C126322002 @default.
- W4231808644 hasConceptScore W4231808644C131872663 @default.
- W4231808644 hasConceptScore W4231808644C196843134 @default.
- W4231808644 hasConceptScore W4231808644C2776551950 @default.
- W4231808644 hasConceptScore W4231808644C2776940978 @default.
- W4231808644 hasConceptScore W4231808644C2777003008 @default.
- W4231808644 hasConceptScore W4231808644C2779234561 @default.
- W4231808644 hasConceptScore W4231808644C2780594696 @default.
- W4231808644 hasConceptScore W4231808644C2909565028 @default.
- W4231808644 hasConceptScore W4231808644C2992130864 @default.
- W4231808644 hasConceptScore W4231808644C54355233 @default.
- W4231808644 hasConceptScore W4231808644C61511704 @default.
- W4231808644 hasConceptScore W4231808644C71924100 @default.
- W4231808644 hasConceptScore W4231808644C86803240 @default.
- W4231808644 hasConceptScore W4231808644C95444343 @default.
- W4231808644 hasIssue "6" @default.
- W4231808644 hasLocation W42318086441 @default.
- W4231808644 hasOpenAccess W4231808644 @default.
- W4231808644 hasPrimaryLocation W42318086441 @default.
- W4231808644 hasRelatedWork W1975554521 @default.
- W4231808644 hasRelatedWork W2008998471 @default.
- W4231808644 hasRelatedWork W2010691534 @default.
- W4231808644 hasRelatedWork W2050651040 @default.
- W4231808644 hasRelatedWork W2077689608 @default.
- W4231808644 hasRelatedWork W2106041012 @default.
- W4231808644 hasRelatedWork W2166176093 @default.
- W4231808644 hasRelatedWork W2228168433 @default.
- W4231808644 hasRelatedWork W2415295741 @default.
- W4231808644 hasRelatedWork W3097410040 @default.
- W4231808644 hasVolume "91" @default.
- W4231808644 isParatext "false" @default.
- W4231808644 isRetracted "false" @default.
- W4231808644 workType "article" @default.